PyInvesting

Market research

KORI.PA Korian

PA EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
779M
P/E ratio
29.44
Analyst target
12
Dividend yield
3.3%
Beta
1.05

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Korian is currently in a long term uptrend where the price is trading 4.4% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

Korian's total revenue sank by 0.0% to $923M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $32M since the same quarter in the previous year.

Finally, its free cash flow grew by 98.6% to $237M since the same quarter in the previous year.

Based on the above factors, Korian gets an overall score of 3/5.